Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Research Article March 20 2025
Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes
Letter March 20 2025
Diabetes Mellitus and APOL1 Genotype Increase the Risk for Chronic Kidney Disease Progression in Sickle Cell Disease
Research Article March 19 2025
NKG2D-mediated cytotoxicity of CD4 cytotoxic T cells in multiple myeloma
Review Article March 19 2025
PI3Kγ in leukemia: class IB PI3 kinase reemerges as a cancer-intrinsic target
Review Article March 19 2025
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT
Brief Report March 19 2025
Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT
Letter March 18 2025
Prognostic Biomarkers in MCL: Insights from the SHINE Trial on the impact of MCL35 score and TP53 Mutation Status
Brief Report March 18 2025
Enhanced α2-3 linked sialylation determines the extended half-life of CHO-rVWF
Discussion March 18 2025
Considerations on the Dose and Schedule of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: Does Dose Matter?
Letter March 18 2025
STAT1-mediated interferon signatures associate with preclinical JAK-inhibitor sensitivity in T-cell acute lymphoblastic leukemia
Brief Report March 16 2025
The neutrophil antigen 3a/b polymorphism in SLC44A2 unexpectedly encodes Csa/Csb red cell antigens
Review Article March 16 2025
How I treat type 1 plasminogen deficiency
Brief Report March 16 2025
Therapeutic switch from plasma to recombinant ADAMTS13 for patients with congenital TTP from Japanese real-world data
Discussion March 16 2025
Proteostasis Disruption in Inherited Bone Marrow Failure Syndromes
Discussion March 16 2025
Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria
Review Article March 16 2025
Biology as vulnerability in follicular lymphoma: genetics, epigenetics, and immunogenetics
Letter March 16 2025
Lymphoid Malignancies in patients with Shwachman-Diamond Syndrome
Letter March 16 2025
Impact of HLA Alloimmunization in Gene-Modified Autologous Stem Cell Transplant For Transfusion-Dependent Thalassemia
Research Article March 16 2025
Itacitinib for the Prevention of IEC Therapy-Associated CRS: Results From the Two-Part Phase 2 INCB 39110-211 Study
Research Article March 16 2025
Single-cell panleukemia signatures of HSPC-like blasts predict drug response and clinical outcome
Research Article March 16 2025
Beyond genotype: challenges in predicting disease risk for carriers of biallelic perforin variants
Research Article March 16 2025
A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia
Research Article March 16 2025
Ruxolitinib combined with dexamethasone for adult patients with newly diagnosed hemophagocytic lymphohistiocytosis in China
Research Article March 16 2025
Loss of BCL7A Permits IRF4 Transcriptional Activity and Cellular Growth in Multiple Myeloma
Research Article March 16 2025
Genetic and epigenetic mechanisms of GPRC5D loss after anti-GPRC5D CAR T-cell therapy in multiple myeloma
Research Article March 16 2025
Blunted CD40-responsive enhancer activation in CREBBP-mutant lymphomas can be restored by enforced CD4 T-cell engagement
Research Article March 16 2025
HLA-haploidentical stem cell transplantation for chronic granulomatous disease: an EBMT-IEWP retrospective study
Research Article March 16 2025
Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study
Research Article March 12 2025
Large-scale dependency and drug screens characterize the therapeutic vulnerabilities of Multiple Myeloma with 1q+
Research Article March 12 2025
Efficacy of Combined CD38 and PD1 Inhibition with Isatuximab and Cemiplimab for Relapsed/Refractory NK/T-Cell Lymphoma
Research Article March 12 2025
A Controlled Trial for Preventing Priapism in Sickle Cell Anemia: Hydroxyurea plus Placebo vs Hydroxyurea plus Tadalafil
Retraction March 12 2025
101(8)3126 Hu (Lichtenstein) retraction
Research Article March 11 2025
Social Determinants of Health and Access to Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
Research Article March 11 2025
Clonal Hematopoiesis Landscape in Frequent Blood Donors
Research Article March 7 2025
Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE study
Letter March 7 2025
Long-term outcomes with single-agent BRAF inhibitor therapy in Erdheim-Chester disease
Brief Report February 28 2025
The bone marrow NK cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy
Review Article February 28 2025
Exploring the thrombus niche: Lessons learned and potential therapeutic opportunities
Review Article February 28 2025
The Future of Follicular Lymphoma Management: Strategies on the Horizon
Review Article February 28 2025
End points and Outcomes in Follicular Lymphoma: What should we measure, how, and why?
Research Article February 27 2025
Decoding functional hematopoietic progenitor cells in the adult human lung
Research Article February 26 2025
Novel Regulators of GVHD Revealed Through Microbiome and Metabolome Patterns Across Distinct Intestinal Regions.
Research Article February 26 2025
Integrated cross-linking by TG2 and FXIII generates hepatoprotective fibrin(ogen) deposits in injured liver
Research Article February 26 2025
Histo-blood group ABO system transferase plasma levels and risk of future venous thromboembolism: The HUNT Study
Research Article February 26 2025
Ibrutinib Lead-in followed by Venetoclax Plus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia - SAKK 34/17
Research Article February 26 2025
STING activation improves T-cell-engaging immunotherapy for acute myeloid leukemia
Research Article February 26 2025
Up-front Blinatumomab Improves MRD Clearance and Outcome in Adult Ph− B-lineage ALL: the GIMEMA LAL2317 Phase 2 Study
Research Article February 26 2025
A CEBPB/IL-1β/TNF-α Feedback Loop Drives Drug Resistance to Venetoclax and MDM2 Inhibitors in Monocytic Leukemia
Research Article February 26 2025
The MURANO study: final analysis and retreatment/crossover substudy results of VenR for patients with relapsed/refractory CLL
Research Article February 26 2025
Synergistic antitumor effect of combined EZH2 and DOT1L inhibition in B-cell lymphoma
Page 1 of 4
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals